ArticleSurgical endoscopy2026
Comparing venous thromboembolism (VTE) prophylaxis and bleeding risks: low molecular weight heparin vs. unfractionated heparin in open repairs of large hernias.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVenous thromboembolism (VTE) remains a major cause of postoperative morbidity and mortality in surgical patients undergoing open large abdominal wall hernia repairs. Uncertainty persists about whether low molecular weight heparin (LMWH) or unfractionated heparin (UFH) provides superior protection against VTEs without increasing bleeding risk. We sought to compare efficacy.
methodsWe conducted a retrospective cohort study of adults undergoing open large abdominal wall hernia repairs at a single institution from 2019 to 2025. Patients received either LMWH or UFH for VTE prophylaxis. The primary endpoint was VTE within 30 days of surgery. Secondary endpoints included bleeding complications (hematomas, transfusion requirements, and reoperations for bleeding). Multivariable logistic regression was performed to assess independent risk factors for VTE and bleeding complications.
resultsA total of 309 patients were included in this study: 156 patients received LMWH and 153 patients received UFH for VTE prophylaxis. The mean patient age was 59.0 ± 12.6 years, mean BMI was 34.5 ± 7.7 kg/m2, and median hernia area was 150 cm
conclusionsIn patients undergoing open large abdominal wall hernia repairs, LMWH and UFH demonstrated similar rates of VTEs and bleeding complications. These findings suggest that either agent is reasonable for prophylaxis in this population, and selection may be guided by patient-specific factors or institutional protocols.
Indexed as
Identifiers
42426395What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.